The 2021 Genitourinary Cancers (GU) Symposium, held virtually, presented practice-changing data in the GU field and novel insights into burning questions, from Feb 11–13.

Leading experts from across the globe presented cutting-edge data, with a focus on translating this new evidence into multidisciplinary care. Explore the news here!

View all videos

GU Cancers 2021

2021 Genitourinary Cancers Symposium
11-13, February

At #AACR21 we spoke to Giacomo Bregni (@JulesBordet) on findings from the REGINA study, evaluating regorafenib, nivolumab and short-course radiotherapy for #RectalCancer

Watch here: http://ow.ly/n7tR50Elpi5

@VJOncology @AACR @OncoAlert #GIsm #OncoAlert #TrialUpdates

Today at #AACR21 I was honored to present results of the phase 3 CheckMate 816 neoadjuvant chemo-nivo lung cancer trial on behalf of all the colleagues, patients & families who made it possible. In this thread I will discuss why we did the study, results and next steps/

#AACR21: Researchers have discovered why cancers driven by an abnormal KRAS gene often become resistant to targeted drugs. Learn more about why the findings may lead to new combination therapies from Mark Awad, MD, PhD (@DrMarkAwad)

👉 Abstract LB002: http://ms.spr.ly/6016VZ5z4

VIDEO: BFAST: High dose alectinib for RET-positive #NSCLC w/ Nir Peled of @SacklerMed

👉http://ow.ly/8ZrT50EhrJu👈

@VJOncology @OncoAlert @IASLC #WCLC21 #LCsm #LungCancer #OncoAlert #Oncology #ClinOnc #MedOnc #TrialUpdate

We caught up w/ @AlexSpiraMDPhD of @VCSpecialists on the use of #Mobocertinib for previously treated #NSCLC with EFGR mutations

Learn more here 👉http://ow.ly/pxB050EllpN👈

@VJOncology @AACR #AACR21 @OncoAlert #LungCancer #LCsm #OncoAlert

Load More

GU Cancers 2021

2021 Genitourinary Cancers Symposium
11-13, February

The 2021 Genitourinary Cancers (GU) Symposium, held virtually, presented practice-changing data in the GU field and novel insights into burning questions, from Feb 11–13.

Leading experts from across the globe presented cutting-edge data, with a focus on translating this new evidence into multidisciplinary care. Explore the news here!

View all videos

At #AACR21 we spoke to Giacomo Bregni (@JulesBordet) on findings from the REGINA study, evaluating regorafenib, nivolumab and short-course radiotherapy for #RectalCancer

Watch here: http://ow.ly/n7tR50Elpi5

@VJOncology @AACR @OncoAlert #GIsm #OncoAlert #TrialUpdates

Today at #AACR21 I was honored to present results of the phase 3 CheckMate 816 neoadjuvant chemo-nivo lung cancer trial on behalf of all the colleagues, patients & families who made it possible. In this thread I will discuss why we did the study, results and next steps/

#AACR21: Researchers have discovered why cancers driven by an abnormal KRAS gene often become resistant to targeted drugs. Learn more about why the findings may lead to new combination therapies from Mark Awad, MD, PhD (@DrMarkAwad)

👉 Abstract LB002: http://ms.spr.ly/6016VZ5z4

VIDEO: BFAST: High dose alectinib for RET-positive #NSCLC w/ Nir Peled of @SacklerMed

👉http://ow.ly/8ZrT50EhrJu👈

@VJOncology @OncoAlert @IASLC #WCLC21 #LCsm #LungCancer #OncoAlert #Oncology #ClinOnc #MedOnc #TrialUpdate

We caught up w/ @AlexSpiraMDPhD of @VCSpecialists on the use of #Mobocertinib for previously treated #NSCLC with EFGR mutations

Learn more here 👉http://ow.ly/pxB050EllpN👈

@VJOncology @AACR #AACR21 @OncoAlert #LungCancer #LCsm #OncoAlert

Load More

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter